Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Dermatologic 1

Conditions

Precancerous Conditions 1Keratosis, Actinic 1Carcinoma, Squamous Cell 1

Interventions

Gemcitabine 2Aminolevulinic Acid 2toripalimab 1tirbanibulin 1ruxolitinib 1potassium oxonate 1penpulimab 1human papillomavirus vaccine, L1 type 16, 18 1gimeracil 1apatinib 1Watchful Waiting 1Transurethral Resection of Prostate 1Toremifene 1Tegafur 1Robotic Surgical Procedures 1Rifampin 1RAD140 1Pregnancy Tests 1Pemetrexed 1ON 01910 1Nivolumab 1Itraconazole 1Irinotecan 1Injections 1Infusions, Intravenous 1Hysterectomy 1Human Papillomavirus DNA Tests 1High-Intensity Focused Ultrasound Ablation 1Excipients 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Excipients × Other neoplasm × Clear all
NCT02844777 2023-01-12

Efficacy and Safety of VDA-1102 Ointment in the Treatment of Actinic Keratosis

Vidac Pharma

Phase 2 Completed
93 enrolled 13 charts
DermatologicOther neoplasm

Carcinoma, Squamous Cell, Precancerous Conditions, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡